Literature DB >> 7417469

Specificity of lysophospholipase D.

R L Wykle, W F Kraemer, J M Schremmer.   

Abstract

The specificity of lysophospholipase D (1-alkyl-sn-glycero-3-phosphoethanolamine ethanolaminehydrolase, EC 3.1.4.39; also works on choline analogs) for 1-alkyl- and 1-acyl-linked substrates was examined using rat liver microsomes. The microsomes were treated with diisopropylphosphorofluoridate to inhibit the hydrolysis of acyl chains from the acyl-linked compounds (1-palmitoyl-sn-glycero-3-phosphocholine and 1-palmitoyl-sn-glycero-3-phosphoethanolamine) and were treated with p-bromophenacyl bromide to block acylation of the compounds tested. In the presence of the inhibitors, 1-alkyl-sn-glycero-3-phosphocholine and 1-alkyl-sn-glycero-3-phosphoethanolamine were hydrolyzed extensively by lysophospholipase D but the corresponding 1-acyl-linked analogs were only negligibly hydrolyzed. Lysophospholipase D therefore appears to be specific for the ether-linked compounds. 1-Alk-1-'-enyl-sn-glycero-3-phosphoethanolamine (lyso plasmalogen) was also tested as a substrate, but a plasmalogenase in the rat liver microsomes rapidly hydrolyzed the compound and we were unable to determine whether it is a substrate for lysophospholipase D. Alkyl-linked substrates containing long-chain acyl groups at the 2-position are not hydrolyzed by the enzymes. We tested 1-alkyl-2-acetoyl-sn-glycero-3-phosphocholine and 1-alkyl-2-acetoyl-sn-glycero-3-phosphoethanolamine to determine if the less bulky, more hydrophilic acetate group would permit hydrolysis by lysophospholipase D; the derivatives did not appear to be attacked, except after hydrolysis of the acetate group. However, in the absence of inhibitors, the acetate groups were rapidly hydrolyzed by microsomal preparations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7417469     DOI: 10.1016/0005-2760(80)90242-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

1.  Activation of macrophages by ether analogues of lysophospholipids.

Authors:  N Yamamoto; B Z Ngwenya; T W Sery; R A Pieringer
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 2.  Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor.

Authors:  A G Rossi; J T O'Flaherty
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Regulation of the biosynthesis of platelet-activating factor in alveolar macrophages.

Authors:  T Sugiura; A Ojima-Uchiyama; Y Masuzawa; M Fujita; Y Nakagawa; K Waku
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 4.  Metabolic processing of PAF.

Authors:  F Snyder
Journal:  Clin Rev Allergy       Date:  1994

Review 5.  Platelet-activating factor: the biosynthetic and catabolic enzymes.

Authors:  F Snyder
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

Review 6.  Biology and biochemistry of platelet-activating factor.

Authors:  J T O'Flaherty; R L Wykle
Journal:  Clin Rev Allergy       Date:  1983-09

7.  Turnover of phosphocholine and phosphoethanolamine in ether-phospholipids of Krebs II ascite cells.

Authors:  A E Tamer; M Record; H Chap; L Douste-Blazy
Journal:  Lipids       Date:  1985-10       Impact factor: 1.880

8.  Metal-ion stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma.

Authors:  A Tokumura; M Miyake; O Yoshimoto; M Shimizu; K Fukuzawa
Journal:  Lipids       Date:  1998-10       Impact factor: 1.880

9.  The degradation of platelet-activating factor and related lipids: susceptibility to phospholipases C and D.

Authors:  R W Wilcox; R L Wykle; J D Schmitt; L W Daniel
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

10.  A phospholipase C with a high specificity for platelet-activating factor in rabbit liver light mitochondria.

Authors:  J Nishihira; T Ishibashi
Journal:  Lipids       Date:  1986-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.